Kylie Keijzer

8PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
Risk of thrombosis and bleeding following CAR T-cell therapy: Insights from the Dutch "Follow that CAR!" registry.

|Nov 25, 2025
Whole-body CD8+ T-cell PET imaging in patients with large B-cell lymphoma before and during CD19-directed CAR T-cell therapy: a phase 2 study.

Janneke W de Boer, Kylie Keijzer, Jaap A van Doesum

|Jul 16, 2025
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections, and survival after CART in R/R LBCL.

Janneke W de Boer, Kylie Keijzer, Suzanne van Dorp

|Mar 06, 2024
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma.

Kylie Keijzer, Janneke W de Boer, Jaap A van Doesum

|Nov 25, 2023
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.

Janneke W de Boer, Kylie Keijzer, Elise R A Pennings

Pageof 2

Frequent Collaborators

6 joint publications

Janneke W de Boer

5 joint publications

Tom van Meerten

3 joint publications

Joost Sp Vermaat

3 joint publications

Anne G H Niezink